INCLINE VILLAGE, Nev., March 1, 2017 /PRNewswire/ — PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today reported financial results for the fourth quarter and year ended December 31, 2016 including: Total revenues of $66.5 million and $244.3 million for the three and twelve months ended December 31, 2016, respectively. GAAP […]